1-5 of 5
Noor M. Khaskhely
Close
Sort by
Journal Articles

HDAC11 plays an essential role in regulating OX40 ligand expression in Hodgkin lymphoma

Daniela Buglio, Noor M. Khaskhely, Kui Shin Voo, Hector Martinez-Valdez, Yong-Jun Liu, Anas Younes
Journal: Blood
Blood (2011) 117 (10): 2910–2917.
https://doi.org/10.1182/blood-2010-08-303701
Published: 2011
Journal Articles

The Histone Deacetylase (HDAC) Inhibitor Entinostat (SNDX-275) Targets Hodgkin Lymphoma through a Dual Mechanism of Immune Modulation and Apoptosis Induction.

Noor M Khaskhely, MD, PhD, Daniela Buglio, MD, Jessica Shafer, MD, Catherine M. Bollard, MD, FRACP, FRCPA, Anas Younes, MD
Journal: Blood
Blood (2009) 114 (22): 1562.
https://doi.org/10.1182/blood.V114.22.1562.1562
Published: 2009
Journal Articles

The Histone Deacetylase Inhibitor MGCD0103 Down Regulates CD30, Activates NF-Kb, and Synergizes with Proteasome Inhibitors by HDAC6 Independent Mechanism in Hodgkin Lymphoma.

Daniela Buglio, MD, Vidya Mamidipudi, Noor M Khaskhely, MD, PhD, Annunziata Gloghini, Antonino Carbone, MD, Carla Heise, Jeffrey M. Besterman, PhD, BSc, Robert E Martell, Kyle J MacBeth, Anas Younes, MD
Journal: Blood
Blood (2009) 114 (22): 3735.
https://doi.org/10.1182/blood.V114.22.3735.3735
Published: 2009
Journal Articles

Differential Effect of the Histone Deacetylase Inhibitors Vorinostat and MGCD0103 in Cell-Free and Cell-Based Assays

Daniela Buglio, MD, Noor M Khaskhely, MD, PhD, George V Georgakis, MD, Anas Younes, MD
Journal: Blood
Blood (2008) 112 (11): 4827.
https://doi.org/10.1182/blood.V112.11.4827.4827
Published: 2008
Journal Articles

Vorinostat inhibits STAT6-mediated T H 2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines

Daniela Buglio, Georgios V. Georgakis, Shino Hanabuchi, Kazuhiko Arima, Noor M. Khaskhely, Yong-Jun Liu, Anas Younes
Journal: Blood
Blood (2008) 112 (4): 1424–1433.
https://doi.org/10.1182/blood-2008-01-133769
Published: 2008
Includes: Supplemental data